56 studies found for:    (HIV infections) [CONDITION] AND vaccine [TREATMENT] | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
(HIV infections) [CONDITION] AND vaccine [TREATMENT] | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Preparing for Adolescent HIV Vaccine Trials in South Africa:
Conditions: HIV Infection;   HIV Infections
Intervention:
2 Not yet recruiting Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever;   Human Immunodeficiency Virus
Interventions: Biological: CYD Dengue Vaccine;   Biological: Placebo (NaCl 0.9%) vaccine group
3 Unknown  Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults
Conditions: Pneumococcal Vaccines;   HIV;   HIV Infections
Intervention: Biological: Prevenar and Pneumo23
4 Unknown  Efficiency of the Hepatitis B Sci-B-Vac Vaccine in HIV Positive Patients
Condition: HIV
Intervention: Biological: Sci-B-Vac
5 Recruiting Safety, Tolerability and Immunogenicity Study of Different Vaccine Schedules With Ad26.Mos.HIV and Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults
Condition: Healthy
Interventions: Biological: Ad26.Mos.HIV;   Biological: Clade C gp140;   Drug: Placebo
6 Unknown  Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults
Conditions: HPV;   HIV
Intervention: Biological: Quadrivalent Human Papillomavirus (6, 11, 16 and 18) vaccine (Gardasil ®)
7 Recruiting A Safety and Immunogenicity Trial of IHV01
Condition: HIV Infection
Interventions: Biological: 0.25 mL FLSC Vaccine Group;   Biological: 0.25 mL Placebo Group;   Biological: 0.5 mL FLSC Vaccine Group;   Biological: 0.5 mL Placebo Group;   Biological: 1.0 mL FLSC Vaccine Group;   Biological: 1.0 mL Placebo Group
8 Recruiting Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults
Conditions: Influenza;   HIV;   Tuberculosis
Intervention: Biological: Trivalent Inactivated Influenza Vaccine
9 Recruiting Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine
Condition: Acquired Immunodeficiency Syndrome
Interventions: Biological: Ad5-gag;   Biological: Placebo
10 Recruiting Study to Evaluate the Safety and Effect of HIVconsv Vaccines in Combination With Histone Deacetylase Inhibitor Romidepsin on the Viral Rebound Kinetic After Treatment Interruption in Early Treated HIV-1 Infected Individuals
Condition: HIV
Interventions: Drug: MVA.HIVconsv vaccine;   Drug: Romidepsin
11 Unknown  Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult Subjects
Condition: HIV Infection
Intervention: Biological: Hepavax-Gene
12 Recruiting Evaluating the Safety, Tolerability, and Immunogenicity of a Prime-Boost Regimen of HIV-1 Nef/Tat/Vif, Env pDNA Vaccine Delivered Intramuscularly With Electroporation and HIV-1 rVSV envC Vaccine in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: HIV-1 nef/tat/vif, env pDNA vaccine;   Biological: rVSV HIV envC vaccine;   Biological: Placebo
13 Unknown  Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers
Condition: HIV Infections
Intervention: Biological: SCBaL/M9
14 Recruiting Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Biological: HIVAX;   Biological: saline solution;   Biological: Saline solution
15 Recruiting Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in Uganda
Condition: HIV/AIDS and Infections
Intervention: Biological: Hepatitis B vaccine
16 Not yet recruiting Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: NYVAC-HIV-PT1 vaccine;   Biological: NYVAC-HIV-PT4 vaccine;   Biological: AIDSVAX B/E vaccine;   Biological: Placebo for DNA/NYVAC/AIDSVAX
17 Unknown  Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers
Conditions: HIV-1;   HIV Infections
Intervention: Biological: MVA.HIVA
18 Unknown  Safety and Immunogenicity of Recombinant HIV Vaccines for HIV/AIDS
Condition: Acquired Immunodeficiency Syndrome
Interventions: Biological: Saline Solution;   Biological: D-GPEi;   Biological: M-GPE
19 Unknown  7-valent Pneumococcal Conjugated Vaccination
Condition: Invasive Pneumococcal Disease
Intervention: Biological: 7-valent pneumococcal conjugated vaccine
20 Recruiting Evaluating the Safety and Immunogenicity of PENNVAX®-GP DNA Vaccine and IL-12 Plasmid, Delivered Via Intradermal or Intramuscular Electroporation in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: PENNVAX®-GP HIV-1 DNA vaccine;   Biological: Interleukin-12 (IL-12) DNA adjuvant;   Biological: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years